Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 in Children with Brain-Based Developmental Disabilities: A Rapid Review

View ORCID ProfileMichèle Dugas, Valérie Carnovale, View ORCID ProfileAndrée-Anne Poirier, Benoit Mailhot, Becky Skidmore, Lena Faust, Carrie Costello, Donna Thomson, View ORCID ProfileAnnette Majnemer, Dan Goldowitz, Steven P. Miller, View ORCID ProfileAnnie LeBlanc
doi: https://doi.org/10.1101/2020.05.01.20088021
Michèle Dugas
1VITAM, Centre de recherche en santé durable, CIUSSS de la Capitale-Nationale, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michèle Dugas
Valérie Carnovale
1VITAM, Centre de recherche en santé durable, CIUSSS de la Capitale-Nationale, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrée-Anne Poirier
1VITAM, Centre de recherche en santé durable, CIUSSS de la Capitale-Nationale, Quebec, Canada
2Institut national d’excellence en santé et en services sociaux, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrée-Anne Poirier
Benoit Mailhot
1VITAM, Centre de recherche en santé durable, CIUSSS de la Capitale-Nationale, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Becky Skidmore
3Independent Information Specialist, Ottawa, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Faust
4Patient-partner (youth) with the CHILD-BRIGHT Network
5Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carrie Costello
6Patient-partner (caregiver) with the CHILD-BRIGHT Network
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna Thomson
6Patient-partner (caregiver) with the CHILD-BRIGHT Network
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Majnemer
7School of Physical & Occupational Therapy, Faculty of Medicine, McGill University; Research Institute of the McGill University Health Centre, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annette Majnemer
Dan Goldowitz
8Department of Medical Genetics, Centre of Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven P. Miller
9Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie LeBlanc
1VITAM, Centre de recherche en santé durable, CIUSSS de la Capitale-Nationale, Quebec, Canada
10Department of Family Medicine and Emergency Medicine, Laval University, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annie LeBlanc
  • For correspondence: annie.leblanc@fmed.ulaval.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The prevalence of symptomatic COVID-19 in children remains low to date. In just a few months, COVID-19 has affected millions of people worldwide, and as of the date of this publication, the pandemic continues. Based on the current available evidence, children do not appear to be at higher risk of contracting COVID-19 than adults. However, children with neurological and neuromuscular conditions are vulnerable to the respiratory complications of other viral infections.

Objectives To assess whether children with brain-based developmental disabilities were more likely to develop COVID-19 and have complications or poorer outcomes following infection.

Methods We conducted a two-week rapid review on studies with primary data regarding children aged between zero and 18 years old with brain-based developmental disabilities, or who were at risk of developing such disabilities, with confirmed or suspected COVID-19. We performed our literature searches on April 18, 2020.

Results Our search strategy identified 538 individual records, of which four were included in our review. Of the 50 COVID-19 pediatric patients reported in the included studies, a total of seven children were at risk of developing brain-based disabilities. Symptoms ranged in severity. However, generally, patients were discharged or saw improvements in their symptoms by the end of the study period. No deaths were reported.

Discussion Our study highlights a knowledge gap regarding the impact of COVID-19 in children with brain-based developmental disabilities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This review was funded by the CHILD-BRIGHT Network and the SPOR Evidence Alliance. Both Networks are supported by the Canadian Institutes of Health Research under Canada’s Strategy for Patient-Oriented Research (SPOR) Initiative.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available upon request to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 in Children with Brain-Based Developmental Disabilities: A Rapid Review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 in Children with Brain-Based Developmental Disabilities: A Rapid Review
Michèle Dugas, Valérie Carnovale, Andrée-Anne Poirier, Benoit Mailhot, Becky Skidmore, Lena Faust, Carrie Costello, Donna Thomson, Annette Majnemer, Dan Goldowitz, Steven P. Miller, Annie LeBlanc
medRxiv 2020.05.01.20088021; doi: https://doi.org/10.1101/2020.05.01.20088021
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 in Children with Brain-Based Developmental Disabilities: A Rapid Review
Michèle Dugas, Valérie Carnovale, Andrée-Anne Poirier, Benoit Mailhot, Becky Skidmore, Lena Faust, Carrie Costello, Donna Thomson, Annette Majnemer, Dan Goldowitz, Steven P. Miller, Annie LeBlanc
medRxiv 2020.05.01.20088021; doi: https://doi.org/10.1101/2020.05.01.20088021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (860)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (250)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8562)
  • Forensic Medicine (4)
  • Gastroenterology (384)
  • Genetic and Genomic Medicine (1753)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1244)
  • Health Policy (621)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (374)
  • Infectious Diseases (except HIV/AIDS) (10303)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1678)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (451)
  • Oncology (929)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (536)
  • Pharmacology and Therapeutics (253)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1770)
  • Public and Global Health (3841)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)